Roman Galetto

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.

Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.

Journal: Journal for immunotherapy of cancer

Published: July 07, 2024

Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.

Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.

Journal: Nature communications

Published: August 08, 2023

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies.

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies.

Journal: Cancer immunology research

Published: November 18, 2022

Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants.

Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants.

Journal: Molecular therapy. Nucleic acids

Published: July 15, 2022

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.

Journal: Cancer research

Published: September 01, 2021

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.

Journal: Nature communications

Published: November 30, 2020

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Journal: Nature communications

Published: July 22, 2020

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.

Journal: Nature communications

Published: July 22, 2020

Gene editing and elimination of latent herpes simplex virus in vivo.

Gene editing and elimination of latent herpes simplex virus in vivo.

Journal: Nature communications

Published: March 26, 2020

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 29, 2018

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: August 11, 2017

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Journal: Stem cell reports

Published: February 06, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026